These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34301246)

  • 21. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths.
    Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
    J Urban Health; 2016 Feb; 93(1):117-30. PubMed ID: 26800987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overdose Awareness and Reversal Trainings at Philadelphia Public Libraries.
    Lowenstein M; Feuerstein-Simon R; Dupuis R; Herens A; Hom J; Sharma M; Sheni R; Encarnacion L; Flaherty C; Cueller M; Cannuscio C
    Am J Health Promot; 2021 Feb; 35(2):250-254. PubMed ID: 32662281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Legacies of the war on drugs: Next of kin of persons who died of opioid overdose and harm reduction interventions in Philadelphia.
    Uzwiak BA; Hudgins A; Pizzicato LN
    Int J Drug Policy; 2021 Nov; 97():103351. PubMed ID: 34252788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naloxone's role in the national opioid crisis-past struggles, current efforts, and future opportunities.
    Bennett AS; Elliott L
    Transl Res; 2021 Aug; 234():43-57. PubMed ID: 33684591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA.
    Bessen S; Metcalf SA; Saunders EC; Moore SK; Meier A; McLeman B; Walsh O; Marsch LA
    Int J Drug Policy; 2019 Dec; 74():144-151. PubMed ID: 31590090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis.
    Neale J; Kalk NJ; Parkin S; Brown C; Brandt L; Campbell ANC; Castillo F; Jones JD; Strang J; Comer SD
    J Subst Abuse Treat; 2020 Oct; 117():108099. PubMed ID: 32811629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The implementation of a naloxone rescue program in university students.
    Panther SG; Bray BS; White JR
    J Am Pharm Assoc (2003); 2017; 57(2S):S107-S112.e2. PubMed ID: 28063773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "A Blessing and a Curse:" Opioid Users' Perspectives on Naloxone and the Epidemic of Opioid Overdose.
    Kline A; Mattern D; Cooperman N; Dooley-Budsock P; Williams JM; Borys S
    Subst Use Misuse; 2020; 55(8):1280-1287. PubMed ID: 32182153
    [No Abstract]   [Full Text] [Related]  

  • 29. Disparities in opioid overdose survival and naloxone administration in Pennsylvania.
    Holmes LM; Rishworth A; King BH
    Drug Alcohol Depend; 2022 Sep; 238():109555. PubMed ID: 35810621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of a collaborative model for opioid overdose prevention on campus.
    Hill LG; Holleran Steiker LK; Mazin L; Kinzly ML
    J Am Coll Health; 2020 Apr; 68(3):223-226. PubMed ID: 30615573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Who receives naloxone from emergency medical services? Characteristics of calls and recent trends.
    Geiger C; Smart R; Stein BD
    Subst Abus; 2020; 41(3):400-407. PubMed ID: 31361589
    [No Abstract]   [Full Text] [Related]  

  • 32. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.
    Donovan E; Case P; Bratberg JP; Baird J; Burstein D; Walley AY; Green TC
    J Urban Health; 2019 Jun; 96(3):367-378. PubMed ID: 30747371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
    Lintzeris N; Monds LA; Bravo M; Read P; Harrod ME; Gilliver R; Wood W; Nielsen S; Dietze PM; Lenton S; Shanahan M; Jauncey M; Jefferies M; Hazelwood S; Dunlop AJ; Greenaway M; Haber P; Ezard N; Malcom A
    Drug Alcohol Rev; 2020 Jan; 39(1):55-65. PubMed ID: 31774221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated With Participation in an Emergency Department-Based Take-Home Naloxone Program for At-Risk Opioid Users.
    Kestler A; Buxton J; Meckling G; Giesler A; Lee M; Fuller K; Quian H; Marks D; Scheuermeyer F
    Ann Emerg Med; 2017 Mar; 69(3):340-346. PubMed ID: 27745764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overdoses due to fentanyl and its analogues (F/FAs) push naloxone to the limit.
    Pergolizzi JV; Dahan A; Ann LeQuang J; Raffa RB
    J Clin Pharm Ther; 2021 Dec; 46(6):1501-1504. PubMed ID: 34111307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature.
    Abdelal R; Banerjee AR; Carlberg-Racich S; Darwaza N; Ito D; Epstein J
    Subst Abus; 2022; 43(1):774-784. PubMed ID: 35112993
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs.
    Reed M; Wagner KD; Tran NK; Brady KA; Shinefeld J; Roth A
    Int J Drug Policy; 2019 Nov; 73():32-35. PubMed ID: 31336291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of opioid overdose: current approaches and recent advances.
    Britch SC; Walsh SL
    Psychopharmacology (Berl); 2022 Jul; 239(7):2063-2081. PubMed ID: 35385972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Inpatient Psychiatric Program Targeting Opioid Overdoses.
    Mahgoub N; O'Connell K; Gevint K; Dedonatis A; Velasco J; Tham A; Cangemi S; Tai FJ; Stellman M; Radosta M; Anthony D
    J Psychiatr Pract; 2020 Jan; 26(1):71-75. PubMed ID: 31913974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of acute opioid toxicity in the outpatient setting.
    Reynolds HH; Orlowski TJ; Huang CC; Phillips CB
    Cutis; 2020 Aug; 106(2):68-69. PubMed ID: 32941559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.